2nd Global Webinar on
Emerging Infectious Diseases & Pediatrics Infections

March 13 2021
A Global Debate on Infectious Diseases: R&D, Therapeutics and Management

Home / Submission & Sessions

Call for Abstracts

  1. Coronavirus (COVID 19)
  2. Perioperative considerations for patients with COVID-19
  3. Future Epidemics: Prediction, Control and Prevention
  4. COVID-19 and Pregnancy
  5.  Novel Trends in Emerging Diseases Management
  6.  Remdesivir in COVID-19  
  7. COVID-19 and Pregnancy ,  Coronavirus 2019 (COVID-19)
  8. Pandemic  COVID-19 and Ischemic Stroke
  9.  Investigational approaches for COVID-19 therapy  
  10. Clinical features of COVID-19 in children  
  11. Management of the intubated COVID-19 patient  
  12. Epidemiology and Infection
  13.  What's new in Infectious and Unprecedented diseases
  14.  Epidemiology and Infection  
  15. Epidemiology and Community Health
  16.  Epidemiology and Disease Control, Trends in Maternal Mortality
  17.  Primary care epidemiology, Paediatric epidemiology
  18.  FLU and Future Epidemic and Pandemic Diseases
  19.  Adaptive Immunity and Herd Immunity
  20.  Neurologic complications of severe COVID-19
  21.  BioEthics and Clinical Trials and Alternative Approaches
  22.  COVID 19 and Phylogenetic analysis
  23.  Therapeutic Strategies
  24. Transmission Prevention Strategies and Basic Methods  
  25. Bacillus anthracis (anthrax)
  26.  Balamuthia mandrillaris (new in FY14)  Bartonella henselae
  27.  BK virus (new in FY14)  Bordetella pertussis (new in FY15)  
  28. Borrelia mayonii (new in FY18)
  29.  Borrelia miyamotoi (new in FY14)  Brucella species (brucellosis)  
  30. Bunyaviruses  Burkholderia mallei (glanders)
  31.  Burkholderia mallei (glanders)  
  32. Burkholderia pseudomallei (melioidosis)  Caliciviruses
  33.  California encephalitis  
  34. Campylobacter jejuni  Category C Priority Pathogens
  35.  Chikungunya Virus  Chlamydia psittaci (Psittacosis)  
  36.  Coxiella burnetii (Q fever)  
  37. Cryptosporidium parvum  Cyclospora cayatanensis
  38.  Dengue  Diarrheagenic E.coli
  39.  Eastern equine encephalitis (EEE)  Ehrlichiosis
  40.  Entamoeba histolytica  
  41. Enterovirus 68 (new in FY15)  Enterovirus 71
  42.  Epsilon toxin (Clostridium perfringens)  
  43. European subtype  Far Eastern subtype  Food- and waterborne pathogens  
  44. Francisella tularensis (tularemia)
  45.  Fungi  Giardia lamblia  Hantaviruses causing Hanta Pulmonary syndrome
  46. Hepatitis E (new in FY14)  Human herpesvirus 6
  47.  Human herpesvirus 8  
  48. Immunological Studies
  49.  Immunology studies that advance our understanding of host defenses applicable to the biodefense effort  
  50. Influenza virus
  51.  Innate Immunity  
  52. Japanese encephalitis virus (JE)
  53.  JC virus (new in FY14)
  54.  Junin, Machupo, Guanarito, Chapare (new in fiscal year (FY14), Lassa, Lujo (new in FY14)
  55.  LaCrosse encephalitis (LACV)  Leptospirosis (new in FY14)
  56.  Listeria monocytogenes  Microsporidia  
  57. Mosquito-borne viruses  Mucormycosis (new in FY14)  Mucosal Immunity
  58.  Naegleria fowleri (new in FY14)  
  59. Naegleria fowleri (new in FY14)  Nipah and Hendra viruses  Omsk Hemorrhagic Fever virus, Alkhurma virus, Kyasanur Forest virus
  60.  Other Rickettsias  
  61. Pathogenic Vibrios  Poliovirus (new in FY15)  Powassan/Deer Tick virus  Prions  Protozoa  Rabies virus
  62.  Research on mechanisms of antimicrobial resistance  
  63. Research on therapeutic approaches that target resistance mechanisms  
  64. Ricin toxin (Ricinus communis)  Rubeola (measles) (new in FY14)  Salmonella
  65.  Shigella species  
  66. Siberian subtype  Tuberculosis, including drug-resistant TB  St. Louis encephalitis virus (SLEV)  
  67. Staphylococcus enterotoxin B (SEB)
  68.  Streptococcus, Group A  Studies of the emergence and/or spread of antimicrobial resistance genes within pathogen populations
  69.  Studies of the emergence and/or spread of antimicrobial-resistant pathogens in human populations  
  70.  Respiratory management for the nonintubated COVID-19 patient  
  71. Viral hemorrhagic fevers  Viruses
  72.  West Nile virus (WNV)  
  73. Yersinia enterocolitica  Western equine encephalitis (WEE)  Yellow fever virus (YFV)  
  74. Yersinia pestis (plague)  Zika virus
  75. Typhus fever (Rickettsia prowazekii)  
  76. Clostridium botulinum toxin (botulism)  Coccidioides spp.
  77. Tickborne encephalitis complex flaviviruses  
  78. Rift Valley Fever, Crimean Congo Hemorrhagic Fever  Hepatitis A  Hepatitis C (new in FY14)  
  79. Variola major (smallpox) and other related pox viruses  CDC and ASN issue
  80. Tickborne encephalitis viruses  Tickborne hemorrhagic fever viruses  Toxoplasma gondii
  81. COVID-19 guidelines for care of patients on dialysis
  82.  Venezuelan equine encephalitis (VEE)  

Will be updated soon